Loading...
Previous studies in the U.S. have suggested that blacks are less likely than whites to achieve virologic suppression on potent antiretroviral therapy (ART) — and that when they do achieve suppression, subsequent failure is more likely and occurs sooner than in whites. To explore these differences further, investigators evaluated data from a large U.S. military cohort of HIV-infected individuals, all of whom have free access to medical care and ART.
The analysis included 691 black patients and 672 white patients who initiated potent ART between 1996 and 2007. The black patients tended to be younger than the white patients at ART initiation and were also more likely to be female, to be enlisted military members rather than officers, to be coin…